GlassScriptPhysician profile
William A Critchlow
NPI 1700296621
$6,565.15
in general payments reported to CMS, 2019-2025
43 companies · $1,545 in 2025
The $1,545 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $253 · 2021: $588 · 2022: $946 · 2023: $1,145 · 2024: $1,245 · 2025: $1,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,934.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,124.29 | 2019-2025 | Ams 700, Lumenis Pulse 120h |
| Sumitomo Pharma America, INC. | $449.06 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $431.39 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Urogen Pharma, INC. | $428.83 | 2023-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $420.51 | 2021-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $408.35 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $303.60 | 2019-2024 | Botox, Lupron Depot |
| Astellas Pharma US INC | $264.65 | 2020-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $250.30 | 2019-2025 | |
| Allergan, INC. | $231.92 | 2019-2022 | |
| Accord Healthcare, INC. | $225.66 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $183.31 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $168.55 | 2022-2024 | Prolaris |
| Olympus America INC. | $153.23 | 2023-2025 | Itind System |
| Astrazeneca Pharmaceuticals LP | $144.93 | 2021-2025 | Lynparza |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $116.65 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $113.21 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Neotract INC. | $111.41 | 2019-2020 | |
| Procept Biorobotics Corporation | $103.00 | 2024-2025 | Aquabeam System |
| Sun Pharmaceutical Industries INC. | $91.41 | 2019-2025 | Yonsa |
| Tolmar, INC. | $89.28 | 2023 | |
| Calyxo, INC. | $79.89 | 2025 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $72.50 | 2021-2022 | |
| Lumenis, INC | $71.42 | 2021 | |
| Cook Medical LLC | $54.40 | 2025 | Cook |
| Verity Pharmaceuticals INC. | $51.88 | 2023 | Trelstar |
| Progenics Pharmaceuticals, INC. | $51.87 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $34.75 | 2023 | Seglentis |
| Blue Earth Diagnostics | $34.63 | 2023-2025 | Posluma |
| Travere Therapeutics, INC. | $30.98 | 2020-2021 | |
| Myovant Sciences INC. | $30.50 | 2021-2022 | |
| Baxter Healthcare | $28.91 | 2022 | |
| Laborie Medical Technologies Corp. | $26.43 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $25.26 | 2022 | |
| Axonics, INC. | $22.39 | 2024 | Axonics |
| Teleflex LLC | $21.36 | 2023 | Urolift |
| Vertex Pharmaceuticals Incorporated | $19.35 | 2025 | |
| Palette Life Sciences, INC. | $18.71 | 2023 | |
| Telix Pharmaceuticals | $18.19 | 2025 | Illuccix |
| Photocure INC | $17.04 | 2025 | Cysview |
| Acerus Pharmaceuticals Corporation | $14.83 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.41 | 2022 | |
| Coloplast Corp | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Critchlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.